Insights

Strategic Focus Attenua, Inc. is a small, virtual biotech focused on developing small molecule therapies for underserved conditions, signaling an opportunity to present lightweight outsourcing, CRO partnerships, and specialized contract manufacturing options aligned with lean drug development needs.

Funding & Growth With a $35M Series A and marquee investors, Attenua is in a growth phase and may seek strategic collaborations, licensing deals, or later-stage partnerships to advance preclinical assets, providing entry points for BD on co-development or asset acquisition discussions.

Leadership & Expertise A seasoned team with prior Big Pharma experience and a high-caliber advisory board offers credibility for partnering with contract research organizations, regulatory consultants, and specialized drug development service providers targeting their programs.

Acquisition History Recent acquisition by CODA Biotherapeutics suggests exposure to exit strategies and integration opportunities; sales teams can explore post-acquisition collaboration models or technology/resource sharing arrangements.

Operational Scale Small headcount and virtual operations indicate a need for scalable, cost-effective service partners in manufacturing, clinical development support, and commercialization readiness to accelerate progress without heavy internal overhead.

Similar companies to Attenua, Inc.

Attenua, Inc. Tech Stack

Attenua, Inc. uses 8 technology products and services including Fusion Ads, WordPress, Font Awesome, and more. Explore Attenua, Inc.'s tech stack below.

  • Fusion Ads
    Advertising
  • Content Management System
  • Font Awesome
    Font Scripts
  • Google Fonts API
    Font Scripts
  • Twemoji
    Font Scripts
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • Google Analytics
    Web Analytics

Media & News

Attenua, Inc.'s Email Address Formats

Attenua, Inc. uses at least 3 email formats:
Attenua, Inc. Email FormatsExamplePercentage
First.Last@attenua.comJohn.Doe@attenua.com
50%
F.Last@attenua.comJ.Doe@attenua.com
30%
FLast@attenua.comJDoe@attenua.com
20%

Frequently Asked Questions

What is Attenua, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Attenua, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Attenua, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Attenua, Inc.'s official website is attenua.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Attenua, Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, Attenua, Inc.'s annual revenue is estimated to be <$1M.

What is Attenua, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Attenua, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Attenua, Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, Attenua, Inc. has approximately 5 employees across 1 continents, including North America. Key team members include Team Assistant: B. J. Explore Attenua, Inc.'s employee directory with LeadIQ.

What industry does Attenua, Inc. belong to?

Minus sign iconPlus sign icon
Attenua, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Attenua, Inc. use?

Minus sign iconPlus sign icon
Attenua, Inc.'s tech stack includes Fusion Ads, WordPress, Font Awesome, Google Fonts API, Twemoji, jQuery, PHP and Google Analytics.

What is Attenua, Inc.'s email format?

Minus sign iconPlus sign icon
Attenua, Inc.'s email format typically follows the pattern of First.Last@attenua.com. Find more Attenua, Inc. email formats with LeadIQ.

How much funding has Attenua, Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2026, Attenua, Inc. has raised $35M in funding. The last funding round occurred on May 01, 2018 for $35M.

When was Attenua, Inc. founded?

Minus sign iconPlus sign icon
Attenua, Inc. was founded in 2015.
Attenua, Inc. logo

Attenua, Inc.

Pharmaceutical ManufacturingCalifornia, United States2-10 Employees

Attenua, Inc. is a small pharmaceutical development company based in San Mateo, California. It operates as a virtual biotech organization focused on creating therapies for conditions that are underserved as large players shift toward specialty drugs and biologics, with the aim of discovering small-molecule blockbuster candidates that could benefit broad patient populations. The team comprises experienced drug development professionals and ex-Big Pharma advisers who have worked at major companies, bringing long-standing expertise to the company’s early-stage program, though the enterprise itself is compact in size. The company’s stated focus is on advancing therapies that address neglected areas of need, leveraging a leadership and advisory group drawn from established industry backgrounds. A notable development in the company’s recent history is its acquisition by CODA Biotherapeutics in February 2020, which marks a transition in its corporate trajectory.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2015
Employees
2-10

Section iconFunding & Financials

  • $35M

    Attenua, Inc. has raised a total of $35M of funding over 1 rounds. Their latest funding round was raised on May 01, 2018 in the amount of $35M as a Series A.

  • <$1M

    Attenua, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.